Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population

Sponsor
Washington University School of Medicine (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04875520
Collaborator
(none)
2,474
5
2
22.8
494.8
21.7

Study Details

Study Description

Brief Summary

The primary goal of this study is to determine the most effective SARS-CoV-2 testing strategy for successful return of in-person school in the under-served communities of St. Louis.

Regular screening testing has been recommended by the CDC as an additive mitigation strategy for in-person schools in areas of high community transmission. We will compare the effectiveness and acceptance of two different school-based testing strategies among students and school staff (symptomatic testing only versus weekly surveillance testing plus symptomatic testing), measuring school-based SARS-CoV-2 transmission through a cluster randomized trial.

Condition or Disease Intervention/Treatment Phase
  • Other: Screening testing strategy
  • Other: No screening testing strategy
N/A

Detailed Description

We will complete a cluster randomized trial to compare the incidence of school-based SARS-CoV-2 transmission between weekly screening testing of students and school staff versus testing only symptomatic students and staff. In this proposal, 16 middle and high schools from five school districts in the St. Louis metropolitan area will be cluster randomized to screening testing plus symptomatic testing versus symptomatic testing alone. The symptomatic testing will be provided to the entire school community as well as household members of students and staff.

The second Aim will evaluate existing mitigation strategies utilized in schools and the rate of school-based SARS-CoV-2 transmission by defining the mitigation strategies utilized in participating schools through survey tools developed with CDC and their impact on school-based COVID-19 transmission and quantifying the rate of COVID-19 transmission in schools and the impact of this transmission on households through extensive interviews and testing of contacts and household members.

Our 3rd Aim involves partnering with community-based organizations to specify and address the social, ethical, and behavioral implications of in-person schooling during the COVID-19 pandemic and the impact of SARS-CoV-2 testing on the school and community. Listening sessions will be utilized to understand barriers and facilitators to testing, ethical concerns of the community in research participation, and the behavioral health impact of lack of in-person schooling.

Study Design

Study Type:
Interventional
Actual Enrollment :
2474 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population
Actual Study Start Date :
May 7, 2021
Actual Primary Completion Date :
May 31, 2022
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Weekly Screening testing plus symptomatic testing

Among 16 middle and high schools, 8 will be randomized to offer students and staff weekly SARS-CoV-2 testing. Additionally, these schools will offer testing for symptomatic students, staff, household members in all age groups.

Other: Screening testing strategy
The intervention we are evaluating is the use of weekly screening testing among students and staff.

Active Comparator: Symptomatic testing

All 16 schools will have testing available for individuals that have symptoms or need a test for other reasons.

Other: No screening testing strategy
a group of schools will not receive screening testing.

Outcome Measures

Primary Outcome Measures

  1. School based transmission [up to one year]

    The average percentage of school-based contacts that test positive per case per school will be calculated

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • A student or staff in one of the five school districts.

  • Household members of a student or staff member in the five school districts.

Exclusion Criteria:
  • People not affiliated with the school.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ferguson-Florissant School District Hazelwood Missouri United States 63042
2 Jennings School District Jennings Missouri United States 63136
3 Pattonville School District Saint Ann Missouri United States 63074
4 Normandy Schools Collaborative Saint Louis Missouri United States 63121
5 The School District of University City University City Missouri United States 63130

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

  • Principal Investigator: Jason G. Newland, MD, Washington University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Jason Newland, Professor Pediatrics, Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT04875520
Other Study ID Numbers:
  • 202104013
First Posted:
May 6, 2021
Last Update Posted:
Aug 24, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jason Newland, Professor Pediatrics, Washington University School of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2022